In addition to these cases, MLPA detected apparent single-exon deletions in two breast cancer patients who were subsequently shown to have microdeletions within the MLPA probe recognition sequences: 364delT in BRCA1 exon 6 and 983delACAG in BRCA2 exon 9. The gene discussed is BRCA2; the disease is breast carcinoma.